TITLE

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant

AUTHOR(S)

Smith, A. R.; Gulbahce, E.; Burke, M. J.; Cao, Q.; MacMillan, M. L.; Tolar, J.; Orchard, P. J.; Blazar, B. R.; Baker, K. S.; Wagner, J. E.; Verneris, M. R.

PUB. DATE

March 2011

SOURCE

Bone Marrow Transplantation;Mar2011, Vol. 46 Issue 3, p368

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Pulmonary cytolytic thrombi (PCT) is an uncommon complication after hematopoietic cell transplantation. Although the pathogenesis is unknown, patients typically respond to systemic corticosteroid treatment. Considering corticosteroids may impair GVL reactions, we reviewed the records of 324 pediatric patients who received a transplant for leukemia and compared the outcomes of those with PCT (n=14) to those without PCT (n=310). PCT patients had a significantly more acute GVHD (aGVHD) and chronic GVHD (cGVHD). Though 3-year non-relapse mortality and OS were similar, there was significantly less relapse in patients with PCT compared to those without PCT (0 vs 28%, P=0.02), regardless of the presence or absence of aGVHD. In multivariate analysis, grade II-IV aGVHD (P=0.02), cGVHD (P=0.01) and development of PCT (P<0.01) were independently associated with less relapse. These data suggest that patients with PCT are at greater risk for GVHD, but at lower risk of leukemia relapse.

ACCESSION #

59192697

Tags: TRANSPLANTATION of organs, tissues, etc. -- Complications;  HEMATOPOIETIC stem cells -- Transplantation;  LUNGS -- Diseases;  LEUKEMIA in children;  CANCER -- Relapse;  ADRENOCORTICAL hormones -- Therapeutic use

 

Related Articles

• Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation. Nakame, T.; Nakame, H.; Kamoi, H.; Koh, H.; Takeoka, Y.; Sakamoto, E.; Kanashima, H.; Nakame, M.; Ohta, K; Terada, Y.; Koh, K.-R.; Yamane, T.; Hino, M. // Bone Marrow Transplantation;Jul2008, Vol. 42 Issue 1, p43 

  Bronchiolitis obliterans syndrome (BOS) and idiopathic pneumonia syndrome (IPS) cause high mortality and impaired survival after allogeneic hematopoietic stem-cell transplantation (allo-HSCT). Early recognition of patients at high risk of developing BOS/IPS may lead to improving the outcome of...

• Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001-2006. Park, Benjamin J.; Pappas, Peter G.; Wannemuehler, Kathleen A.; Alexander, Barbara D.; Anaissie, Elias J.; Andes, David R.; Baddley, John W.; Brown, Janice M.; Brumble, Lisa M.; Freifeld, Alison G.; Hadley, Susan; Herwaldt, Loreen; Ito, James I.; Kauffman, Carol A.; Lyon, G. Marshall; Marr, Kieren A.; Morrison, Vicki A.; Papanicolaou, Genovefa; Patterson, Thomas F.; Perl, Trish M. // Emerging Infectious Diseases;Oct2011, Vol. 17 Issue 10, p1855 

  Recent reports describe increasing incidence of non-Aspergillus mold infections in hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients. To investigate the epidemiology of infections with Mucorales, Fusarium spp., and Scedosporium spp. molds, we analyzed data from the...

• Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes. J-H Lee, L.; S-J Choi, L.; J-H Lee, L.; Y-S Lee, L.; W-K Kim, L.; J-S Lee, L.; K-H Lee, L.; S. Kim; M. Seol, L. // Bone Marrow Transplantation;Apr2004, Vol. 33 Issue 7, p729 

  Summary:The outcomes of patients who experience the failure to reconstitute a trilineage of blood cells after initial neutrophil engraftment were evaluated in 178 patients with hematologic disorders, who underwent allogeneic HCT. Of 165 qualified patients (five with primary engraftment failure;...

• Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Martin, P. J.; Flowers, M. E.; Nichols, W. G.; Clark, J. G.; Chien, J. W. // Bone Marrow Transplantation;Apr2004, Vol. 33 Issue 7, p759 

  Summary:The clinical significance of early airflow decline after myeloablative allogeneic hematopoietic SCT is uncertain. We performed a retrospective cohort analysis to determine if airflow decline by day 100 is associated with later development of transplant-related airflow obstruction (AFO)...

• Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry. Martino, M; Ballestrero, A; Zambelli, A; Secondino, S; Aieta, M; Bengala, C; Liberati, A M; Zamagni, C; Musso, M; Aglietta, M; Schiavo, R; Castagna, L; Rosti, G; Bruno, B; Pedrazzoli, P // Bone Marrow Transplantation;Mar2013, Vol. 48 Issue 3, p414 

  The median survival of women with metastatic breast cancer (MBC) is 18-24 months, and fewer than 5% are alive and disease free at 5 years. We report toxicity and survival in a cohort of MBC patients receiving high-dose chemotherapy (HDC) with autologous hematopoietic SCT (AHSCT) in Italy between...

• Rhizomucor and Scedosporium Infection Post Hematopoietic Stem-Cell Transplant. Marques, Dânia Sofia; Vaz, Carlos Pinho; Branca, Rosa; Campilho, Fernando; Lamelas, Catarina; Afonso, Luis Pedro; Jacome, Manuel; Breda, Eduardo; Monteiro, Eurico; Júnior, António Campos // Case Reports in Medicine;2011, p1 

  Hematopoietic stem-cell transplant recipients are at increased risk of developing invasive fungal infections. This is a major cause of morbidity and mortality. We report a case of a 17-year-old male patient diagnosed with severe idiopathic acquired aplastic anemia who developed fungal...

• Compromised recovery of natural interferon-a/b-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration. Kitawaki, T; Kadowaki, N; Ishikawa, T; Ichinohe, T; Uchiyama, T // Bone Marrow Transplantation;Jul2003, Vol. 32 Issue 2, p187 

  Summary:Delayed recovery of the immune system is a major cause of post-transplant infection. Natural interferon (IFN)-a/?-producing cells (IPC) appear to play a critical role in inducing effective immune responses to a variety of microbial pathogens by producing an enormous amount of IFN-a/? and...

• A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, ? glutamyl transferase, donor type and cell dose. Sormani, M P; Oneto, R; Bruno, B; Fiorone, M; Lamparelli, T; Gualandi, F; Raiola, A M; Dominietto, A; Van Lint, M T; Frassoni, F; Bruzzi, P; Bacigalupo, A // Bone Marrow Transplantation;Jul2003, Vol. 32 Issue 2, p205 

  Summary:We have previously described a scoring system for patients undergoing hemopoietic stem cell transplantation (HSCT) based on day +7 blood urea nitrogen (BUN) and serum bilirubin levels. We have revised that scoring system using a formal multivariate approach based on a training phase (305...

• Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Sato, M; Nakasone, H; Oshima, K; Ishihara, Y; Wada, H; Sakamoto, K; Kawamura, K; Ashizawa, M; Machishima, T; Terasako, K; Kimura, S; Kikuchi, M; Okuda, S; Tanihara, A; Yamazaki, R; Tanaka, Y; Kanda, J; Kako, S; Nishida, J; Kanda, Y // Bone Marrow Transplantation;May2013, Vol. 48 Issue 5, p698 

  Various biomarkers have been investigated with regard to their ability to predict the outcome of allogeneic hematopoietic SCT (HSCT). In this study, we retrospectively reviewed 90 recipients who received HSCT between 2007 and 2011 in our institution, and evaluated the predictive value of the...

Read the Article